Published online by Cambridge University Press: 17 April 2020
The aim of this work was:
• to understand and measure the emotional effects of chemotherapy-induced alopecia by exploring self-esteem, body image, anxiety and depression in cancer patients
• to analyse the strategies used to cope with hair loss.
This was a cross-sectional study. It involved the use of a questionnaire with patients from the medical oncology unit of the Habib Bourguiba University Hospital. The questionnaire included Socio-demographic data, type and stage of cancer, data concerning the alopecia (partial or total) and its impact on social life, work, and sexuality.
Four measurement scales were used:
- Rosenberg's Self-Esteem scale,
- Bruchon-Schweitzer's Body image questionnaire (QIC)
- Hospital Anxiety and Depression scale (HAD)
- Brief cope
Preliminary study
It was a population of 24 patients. 55.2% were males. The mean age was 45.9 years. 75.9% were married.
Alopecia was the most distressing side effect of chemotherapy in 30.4% of cases. 45.8% were suffering from the stigma of the alopecia which disturbed their social interaction. It led to a loss in self-confidence in half of patients and altered sexuality in third. Self-esteem was low in 34.5%.
The average score of the scale body image was 61. 41.4% of patients were anxious and only 27.6% were depressed.
The religion was the major strategy used to cope with alopecia.
The findings suggest that the chemotherapy-induced alopecia has the potential to affect various aspects of patient's life, but Tunisian cancer patients seems to be less affected compared with literature.
Comments
No Comments have been published for this article.